Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Phthalate metabolites in maternal and cord plasma and their relations to other selected endocrine disruptors and steroids

L. Kolatorova, J. Vitku, A. Vavrous, R. Hampl, K. Adamcova, M. Simkova, A. Parizek, L. Starka, M. Duskova

. 2018 ; 67 (Suppl. 3) : S473-S487.

Language English Country Czech Republic

Document type Journal Article

Endocrine disruptors (EDs) are known to have harmful effects on the human endocrine system; special effort is actually given to the exposure during pregnancy. Humans are usually exposed to a mixture of EDs, which may potentiate or antagonize each other, and the combined effect may be difficult to estimate. The main phthalate monoesters monoethyl-, mono-n-butyl-, monoisobutyl-, monobenzyl-, mono-(2-ethylhexyl)-, mono-(2-ethyl-5-hydroxyhexyl)- and mono-(2-ethyl-5-oxohexyl) phthalate were determined in 18 maternal (37th week of pregnancy) and cord plasma samples using liquid chromatography-tandem mass spectrometry. Previously determined levels of selected bisphenols, parabens and steroids were also considered in this study. In cord blood, there were significantly higher mono-n-butyl phthalate levels than in maternal blood (p=0.043). The results of multiple regression models showed that maternal plasma phthalates were negatively associated with cord plasma androstenedione, testosterone and dehydroepiandrosterone and positively associated with estradiol and estriol. For estriol, a cumulative association was also observed for sumabisphenols. To the best of our knowledge, this is the first pilot study evaluating the effect of prenatal exposure by multiple EDs on newborn steroidogenesis. Our results confirmed phthalate accumulation in the fetal area and disruption of fetal steroidogenesis. This preliminary study highlights the negative impacts of in utero EDs exposure on fetal steroidogenesis.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19005358
003      
CZ-PrNML
005      
20210601145939.0
007      
ta
008      
190204s2018 xr f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.933962 $2 doi
035    __
$a (PubMed)30484674
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Kolátorová Sosvorová, Lucie $7 xx0140729 $u Department of Steroids and Proteofactors, Institute of Endocrinology, Prague, Czech Republic
245    10
$a Phthalate metabolites in maternal and cord plasma and their relations to other selected endocrine disruptors and steroids / $c L. Kolatorova, J. Vitku, A. Vavrous, R. Hampl, K. Adamcova, M. Simkova, A. Parizek, L. Starka, M. Duskova
520    9_
$a Endocrine disruptors (EDs) are known to have harmful effects on the human endocrine system; special effort is actually given to the exposure during pregnancy. Humans are usually exposed to a mixture of EDs, which may potentiate or antagonize each other, and the combined effect may be difficult to estimate. The main phthalate monoesters monoethyl-, mono-n-butyl-, monoisobutyl-, monobenzyl-, mono-(2-ethylhexyl)-, mono-(2-ethyl-5-hydroxyhexyl)- and mono-(2-ethyl-5-oxohexyl) phthalate were determined in 18 maternal (37th week of pregnancy) and cord plasma samples using liquid chromatography-tandem mass spectrometry. Previously determined levels of selected bisphenols, parabens and steroids were also considered in this study. In cord blood, there were significantly higher mono-n-butyl phthalate levels than in maternal blood (p=0.043). The results of multiple regression models showed that maternal plasma phthalates were negatively associated with cord plasma androstenedione, testosterone and dehydroepiandrosterone and positively associated with estradiol and estriol. For estriol, a cumulative association was also observed for sumabisphenols. To the best of our knowledge, this is the first pilot study evaluating the effect of prenatal exposure by multiple EDs on newborn steroidogenesis. Our results confirmed phthalate accumulation in the fetal area and disruption of fetal steroidogenesis. This preliminary study highlights the negative impacts of in utero EDs exposure on fetal steroidogenesis.
650    _2
$a dospělí $7 D000328
650    _2
$a endokrinní disruptory $x škodlivé účinky $x krev $x farmakologie $7 D052244
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fetální krev $x účinky léků $x metabolismus $7 D005312
650    _2
$a lidé $7 D006801
650    12
$a matka - expozice noxám $x škodlivé účinky $7 D018811
650    _2
$a kyseliny ftalové $x škodlivé účinky $x krev $x farmakologie $7 D010795
650    _2
$a pilotní projekty $7 D010865
650    _2
$a placentární oběh $x účinky léků $x fyziologie $7 D021041
650    _2
$a těhotenství $7 D011247
650    _2
$a steroidy $x antagonisté a inhibitory $x krev $7 D013256
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vítků, Jana $7 xx0211876 $u Department of Steroids and Proteofactors, Institute of Endocrinology, Prague, Czech Republic
700    1_
$a Vavrouš, Adam $7 _AN087637 $u Unit for Chemical Safety of Products, National Institute of Public Health, Prague, Czech Republic; Department of Analytical Chemistry, Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Hampl, Richard, $d 1941- $7 jo20000074077 $u Department of Steroids and Proteofactors, Institute of Endocrinology, Prague, Czech Republic
700    1_
$a Adamcova, K $u Department of Steroids and Proteofactors, Institute of Endocrinology, Prague, Czech Republic
700    1_
$a Simkova, M. $u Department of Steroids and Proteofactors, Institute of Endocrinology, Prague, Czech Republic; Faculty of Food and BiochemicalTechnology, University of Chemistry and Technology, Prague, Czech Republic
700    1_
$a Pařízek, Antonín, $d 1959- $7 mzk2005294935 $u Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles Universityand General Teaching Hospital, Prague, Czech Republic
700    1_
$a Stárka, Luboslav, $d 1930- $7 jn19990209795 $u Department of Steroids and Proteofactors, Institute of Endocrinology, Prague, Czech Republic
700    1_
$a Dušková, Michaela $7 xx0080454 $u Department of Steroids and Proteofactors, Institute of Endocrinology, Prague, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 67, Suppl. 3 (2018), s. S473-S487
773    0_
$t Dr. Karel Šilink - The 110th anniversary of the birth $g (2018), s. S473-S487 $w MED00206981
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30484674 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20190204 $b ABA008
991    __
$a 20210601145936 $b ABA008
999    __
$a ok $b bmc $g 1377931 $s 1043563
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 67 $c Suppl. 3 $d S473-S487 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
BMC    __
$a 2018 $d S473-S487 $m Dr. Karel Šilink - The 110th anniversary of the birth $x MED00206981
LZP    __
$b NLK118 $a Pubmed-20190204

Find record

Citation metrics

Logged in users only

Archiving options

Loading data ...